Status:

UNKNOWN

Reversal With Low Doses of Sugammadex in Patients Undergoing Non-cardiac Surgery

Lead Sponsor:

The Hospital of Vestfold

Conditions:

Postoperative Residual Curarization

Neuromuscular Block

Eligibility:

All Genders

18-100 years

Phase:

PHASE4

Brief Summary

Neuromuscular blocking agents (NMBA) are among the most commonly used drugs during general anesthesia and may induce complete muscle paralysis.They are used clinically to facilitate endotracheal intub...

Detailed Description

Doses of study drug will be 0 mg/kg Ideal Body Weight (IBW), 0.25 mg/kg IBW, 0.50 mg/kg IBW, 1.0 mg/kg IBW and 2.0 mg/kg IBW. TOF will be measured every 10th second until full reversal.

Eligibility Criteria

Inclusion

  • Patient, both genders, undergoing any elective in-hospital surgical procedure under general anesthesia requiring rocuronium neuromuscular block.
  • ASA I-IV
  • Signed informed consent

Exclusion

  • Patient less than 18 years of age
  • Patient participating in another clinical study which could interfere with TOF trial.
  • Patient with neuromuscular disease
  • Patient from ICU
  • BMI \> 30.0 kg/m2
  • Patient scheduled for local or regional anesthesia only
  • Patient undergoing general anesthesia without rocuronium
  • Patient with hypersensitivity to NMBAs or sugammadex. Also hypersensitivity to any active substance or to any of the following excipient: Hydrochloric acid 3.7% (to adjust pH) and/or sodium hydroxide (to adjust pH) Water for injections .
  • Renal dysfunction (GFR\<30 mL/min/1,73m2)
  • Hepatic dysfunction
  • Patient who have received sugammadex in the last 24 h.
  • Pregnant or breastfeeding woman. Women in childbearing age must have a negative pregnant test before inclusion.
  • Bradycardia (puls \<40)
  • Hypotension (Systolic BP \<90 mmHg)

Key Trial Info

Start Date :

August 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2019

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT03460509

Start Date

August 1 2018

End Date

December 1 2019

Last Update

May 30 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Reversal With Low Doses of Sugammadex in Patients Undergoing Non-cardiac Surgery | DecenTrialz